VIRTUAL WORKSHOP
Fit-for-Purpose Animal Models
20 January 2026
This interactive online workshop explored and discussed the extent to which current animal models reflect the human spectrum, from Mtb infection to TB disease, and considered their application to human-relevant outcomes (resistance to infection and containment of disease). Speakers and panelists also discussed how to use these models to advance candidates from the lab to the clinic.
Read the meeting summary.
Presentations for which we have permission to post can be accessed in the agenda below.
agenda
9:00 - 9:05 am
Welcome and Introductory Remarks
David Lewinsohn, Chair, Working Group on New TB Vaccines (WGNV)
9:05 - 10:10am
Panel 1: Resistance to Mtb infection
Session Chairs: Katrin Eichelberg, National Institute for Allergy and Infectious Diseases (NIAID) | Monika Looney, South African Tuberculosis Vaccine Initiative
Presentations and Speakers:
- The NHP Model: P. Ling Lin, University of Pittsburgh School of Medicine
- New Approaches to the Mouse Model: Shabaana Khader, University of Chicago
- Other Animal Models: Bjӧrn Corleis, Friedrich-Loeffler-Institut
10:10 - 10:20 am
BREAK
10:20 - 11:10 am
Panel 2: Containment and/or elimination of Mtb
Session Chairs: Alison Kraigsley, Gates Foundation | Elly van Riet, TuBerculosis Vaccine Initiative (TBVI)
Presentations and Speakers:
- The NHP Model: Frank Verreck, BPRC
- New Approaches to the Mouse Model: Kevin Urdahl, Seattle Children's Research Institute
11:10 - 11:50 am
Interactive Panel Discussion
All session chairs and speakers
11:50 - 12:00pm
Closing
David Lewinsohn, WGNV Chair
Jennifer Woolley, WGNV Secretariat
NIAID does not endorse nor should endorsement be implied of the Working Group on New TB Vaccines, its products or services.